Literature DB >> 26815656

Correction: A Peptide Derived from the HIV-1 gp120 Coreceptor-Binding Region Promotes Formation of PAP248-286 Amyloid Fibrils to Enhance HIV-1 Infection.

Jinquan Chen, Ruxia Ren, Suiyi Tan, Wanyue Zhang, Xuanxuan Zhang, Fei Yu, Tianrong Xun, Shibo Jiang, Shuwen Liu, Lin Li.   

Abstract

Entities:  

Year:  2016        PMID: 26815656      PMCID: PMC4729527          DOI: 10.1371/journal.pone.0147679

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
Fig 7 is incorrect. The figure is incomplete. The authors have provided a new, completed version here.
Fig 7

Schematic representation of EP2’s mechanism in promoting PAP248-286 amyloid fibril formation and enhancing HIV-1 infection.

(A) PAP248-286 amyloid fibrils enhanced HIV-1 infection. Under agitation at 37°C, PAP248-286 slowly (~ 24 h) formed amyloid fibrils, which enhanced HIV-1 infection. (B) EP2 promoted the formation of PAP248-286 amyloid fibrils. Without agitation, EP2 rapidly (~ 1 min) self-assembled into nanofibers. These nanofibers accelerated (~ 4 h) the formation of amyloid fibrils, which enhanced HIV-1 infection.

Schematic representation of EP2’s mechanism in promoting PAP248-286 amyloid fibril formation and enhancing HIV-1 infection.

(A) PAP248-286 amyloid fibrils enhanced HIV-1 infection. Under agitation at 37°C, PAP248-286 slowly (~ 24 h) formed amyloid fibrils, which enhanced HIV-1 infection. (B) EP2 promoted the formation of PAP248-286 amyloid fibrils. Without agitation, EP2 rapidly (~ 1 min) self-assembled into nanofibers. These nanofibers accelerated (~ 4 h) the formation of amyloid fibrils, which enhanced HIV-1 infection.
  1 in total

1.  A Peptide Derived from the HIV-1 gp120 Coreceptor-Binding Region Promotes Formation of PAP248-286 Amyloid Fibrils to Enhance HIV-1 Infection.

Authors:  Jinquan Chen; Ruxia Ren; Suiyi Tan; Wanyue Zhang; Xuanxuan Zhang; Fei Yu; Tianrong Xun; Shibo Jiang; Shuwen Liu; Lin Li
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.